Ngā hua rapu kaituhi :: APM

1

Medium for the accumulation of extracellular hemolysin and protease by Aeromonas hydrophila. mā Riddle, L M, Graham, T E, Amborski, R L

I whakaputaina 1981

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
2

Essential oils for managing Pratylenchus penetrans on Easter lilies mā Westerdahl, B. B., Giraud, D., Riddle, L. J., Anderson, C. A.

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
3

Problems Associated with Crop Rotation for Management of Pratylenchus penetrans on Easter Lily mā Westerdahl, B. B., Giraud, D., Etter, S., Riddle, L.J., Anderson, C. A.

I whakaputaina 1998

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
4

Epitope mapping of the human immunodeficiency virus type 1 gp120 with monoclonal antibodies. mā Dowbenko, D, Nakamura, G, Fennie, C, Shimasaki, C, Riddle, L, Harris, R, Gregory, T, Lasky, L

I whakaputaina 1988

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
5

Identification of the binding site in intercellular adhesion molecule 1 for its receptor, leukocyte function-associated antigen 1. mā Fisher, K L, Lu, J, Riddle, L, Kim, K J, Presta, L G, Bodary, S C

I whakaputaina 1997

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
6

Management Options for Pratylenchus penetrans in Easter Lily mā Westerdahl, B. B., Giraud, D., Etter, S., Riddle, L. J., Radewald, J. D., Anderson, C. A., Darso, J.

I whakaputaina 2003

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
7

Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity. mā Ashkenazi, A, Smith, D H, Marsters, S A, Riddle, L, Gregory, T J, Ho, D D, Capon, D J

I whakaputaina 1991

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
8

Expression and immunogenicity of the extracellular domain of the human immunodeficiency virus type 1 envelope glycoprotein, gp160. mā Berman, P W, Riddle, L, Nakamura, G, Haffar, O K, Nunes, W M, Skehel, P, Byrn, R, Groopman, J, Matthews, T, Gregory, T

I whakaputaina 1989

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
9

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. mā Aiello, L P, Pierce, E A, Foley, E D, Takagi, H, Chen, H, Riddle, L, Ferrara, N, King, G L, Smith, L E

I whakaputaina 1995

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
10

Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120. mā Berman, P W, Groopman, J E, Gregory, T, Clapham, P R, Weiss, R A, Ferriani, R, Riddle, L, Shimasaki, C, Lucas, C, Lasky, L A

I whakaputaina 1988

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
11

Neutralization of multiple laboratory and clinical isolates of human immunodeficiency virus type 1 (HIV-1) by antisera raised against gp120 from the MN isolate of HIV-1. mā Berman, P W, Matthews, T J, Riddle, L, Champe, M, Hobbs, M R, Nakamura, G R, Mercer, J, Eastman, D J, Lucas, C, Langlois, A J

I whakaputaina 1992

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i: